Robert E. Winkler

Robert E. Winkler, MD, is an accomplished medical professional with extensive experience in oncology and clinical development. Currently serving on the Board of Directors and as an Advisor for MyChild'sCancer, Robert is dedicated to ensuring that critical life-saving information is accessible to caregivers of children with cancer. As a Strategic Advisor at TrialJectory, Robert leverages artificial intelligence to connect biopharmaceutical companies with appropriate cancer patients for clinical trials. With a longstanding history in various leadership roles, including Senior Vice President at Taiho Oncology, where Robert successfully led the clinical development team to achieve the company's first global approval, Robert has also held positions at prominent organizations such as Novartis Oncology and Amicus Therapeutics. Academic credentials include an MD from The Hebrew University of Jerusalem and additional business education from Rutgers Business School.